Individuals with type 2 diabetes and obesity face a high risk for developing cardiovascular disease and experiencing major cardiac events or conditions, including myocardial infarction, stroke, heart failure, cardiovascular death, and peripheral arterial disease
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP
Im very pleased with Vitastir
Our team at Vytality Blu Health & Medspa closely monitors your response to therapy, ensuring safe, effective, and personalised care throughout your treatment journey
OPTIMAL DX MEMBERS CLICK HERE to learn more about GLP-1, phytochemicals, health benefits, etc.